De. Keil et al., ROLE OF DECOMPOSITION PRODUCTS IN SODIUM METHYLDITHIOCARBAMATE-INDUCED IMMUNOTOXICITY, Journal of toxicology and environmental health, 47(5), 1996, pp. 479-492
Sodium methyldithiocarbamate (SMD) is a widely used agricultural agent
that causes immunological changes in B6C3F1 mice. The most prominent
effects of SMD include a decrease in thymus weight and percentage of C
D4(+)CD8(+) thymocytes, an increase in spleen weight, an increase in t
he percentage of neutrophils in the blood, a decrease in the percentag
e of lymphocytes in the blood, and a decrease in natural killer (NK) c
ell activity in the spleen. The mechanism by which SMD causes these ch
anges is unknown, and the relative importance of the parent compound a
nd its decomposition products is not known. In addition, it is not kno
wn if these effects are unique to mice, or if other mammals are affect
ed similarly. This prompted the present investigation of the major dec
omposition product of SMD, methylisothiocyanate (MITC), and two minor
products, methylamine and carbon disulfide, in mice. Equimolar dosages
of methylamine and carbon disulfide caused minimal immunological chan
ges, and these changes were not characteristic of those noted for SMD.
In contrast, MITC significantly decreased thymus weight and cellulari
ty and changed peripheral white blood cell populations in a manner sim
ilar to that noted for an equimolar dosage of SMD. However, MITC did n
ot significantly affect NK cell activity or increase spleen weight. Th
us, MITC is probably responsible for some of the immunological changes
noted in SMD-treated mice. The remaining changes are not produced by
MITC, methylamine, or carbon disulfide. Thus, it is likely that the pa
rent compound or a synergistic action of the parent compound with one
or more of the decomposition products is responsible for these remaini
ng changes (increased spleen weight and decreased splenic NK cell acti
vity). Data are also presented that indicate that SMD-induced thymic a
trophy occurs in rats as well as mice and that the dosage required to
decrease thymus weight by 50% is lower for rats than for mice. Investi
gations of other mammals are needed to indicate SMD's potential as a h
uman immunotoxicant and to compare the role of MITC in the immunotoxic
effects of SMD in different species.